Evie Merinopoulou

Senior Director, Real-World Evidence

Evie Merinopoulou is Senior Director, Real-World Evidence, at Cytel. She is a health economist and real-world data scientist working on applications of real-world evidence in support of regulatory and HTA decision-making.

Evie has worked in the healthcare consulting industry for over 10 years, currently leading the design and execution of observational research projects using global real-world data. She particularly focuses on projects involving real-world synthetic control arms, quantitative bias analysis, head-to-head comparisons using target trial emulation, and transportability analysis.

Evie Merinopoulou

Related Articles

External Validity Bias in HTA Submissions: A Case for Transportability Methods
Blog
August 13, 2024
External Validity Bias in HTA Submissions: A Case for Transportability Methods
Read More
The Role of External Data in Oncology Drug Development
Blog
August 1, 2024
The Role of External Data in Oncology Drug Development
Read More
Planning Strategies for Externally Controlled Trials: Insights from ISPOR US 2024
Blog
June 18, 2024
Planning Strategies for Externally Controlled Trials: Insights from ISPOR US 2024
Read More
Reinforcement Learning: A Promising Tool for Predicting Optimal Treatment in Complex Diseases
Blog
November 3, 2023
Reinforcement Learning: A Promising Tool for Predicting Optimal Treatment in Complex Diseases
Read More